SCHEMBL4158115

SCHEMBL4158115

CN(C(=O)N(C(=O)c1c(F)cccc1F)S(=O)(=O)c1ccccc1)c1ccc(SC(F)(F)F)cc1F

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NR1H3 Q13133 4/20 0.38
SIRT2 Q8IXJ6 2/20 0.37
LMNA P02545 2/20 0.33
MAPT P10636 1/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
HTT P42858 1/20 0.33
HSD11B1 P28845 1/20 0.33
TDP1 Q9NUW8 2/20 0.32
RORC P51449 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
NR1I2 O75469 2/20 0.31
ALDH1A1 P00352 1/20 0.31
NR1H2 P55055 2/20 0.31
KMT2A Q03164 2/20 0.31
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4142579 0.88 TDP1 (0.34) SIRT2LMNAMAPTTSHRMAPK1
SCHEMBL4164385 0.86 MAPT (0.32) LMNAMAPTTSHRMAPK1HTT
SCHEMBL4154435 0.82 RORC (0.36) SIRT2LMNAMAPTTSHRMAPK1
SCHEMBL4142662 0.81 RORC (0.34) SIRT2LMNAMAPTTSHRMAPK1
SCHEMBL4156743 0.80 RORC (0.35) SIRT2LMNAMAPTTSHRMAPK1
SCHEMBL4159030 0.80 TDP1 (0.45) LMNAMAPTTSHRMAPK1HTT
SCHEMBL4157996 0.79 RORC (0.35) LMNAMAPTTSHRMAPK1HTT
SCHEMBL4142611 0.79 RORC (0.35) SIRT2LMNAMAPTTSHRMAPK1
SCHEMBL4144806 0.79 RORC (0.35) SIRT2LMNAMAPTTSHRMAPK1
SCHEMBL4154572 0.79 RORC (0.34) LMNAMAPTTSHRMAPK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
EP-1937629-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2008-07-02 EP disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176786-A1 Benzoylurea Compounds and Use Thereof BTK, BRIX1, NFXL1 NR1H3 3326/4885SIRT2 2533/4885LMNA 2141/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.